Rebecca Taub, Director at MADRIGAL PHARMACEUTICALS, INC. (MDGL), sold 2,238 shares at $490.77 ($1.1M) on 2026-01-20, disclosed to the SEC on 2026-01-20.
Seasonal sale ($1.1M) by Director — this insider has traded MDGL in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| MDGL | SELL | 2026-01-13 | $242K | — | Filing → |
| MDGL | SELL | 2026-01-13 | $18.9M | — | Filing → |
| MDGL | SELL | 2025-12-12 | $20.5M | — | Filing → |